Autumn 2022 Newsletter Now Online
Our Autumn 2022 newsletter with information about our documentary release, clinical trial progress, upcoming events, and much more is now available. Find it here.
Our Autumn 2022 newsletter with information about our documentary release, clinical trial progress, upcoming events, and much more is now available. Find it here.
Please join us in thanking our August Volunteers of the Month: Chad and Mariah Cavallero. The Cavallero’s hosted a golf tournament at Pelican Lakes on August 10th. They raised over $15,000…
August 1, 2022 – The atorvastatin experimental proof of concept trial to treat cavernous malformations with symptomatic hemorrhage, hosted at the University of Chicago, has completed enrollment. We congratulate and…
Alliance to Cure Cavernous Malformation has designated Stanford Health Care in Stanford, California a Center of Excellence in the treatment of cavernous malformations. The Stanford Health Care Neuroscience Health Center…
UCLA Health Designated as Clinical Center for Treatment of Cavernous Malformations, a Vascular Disorder of the Nervous System Hospital recognized by the Alliance to Cure Cavernous Malformation for providing high-quality,…